Report Code : CVMI24071653 | Published Date : July 16, 2024
The Atopic Dermatitis Treatment Market is experiencing significant growth, fueled by the rising incidence of allergic skin conditions, greater adoption of biologics, and advancements in non-steroidal treatments. Valued at USD XX billion in 2023, the market is projected to grow at a CAGR of XX% from 2024 to 2031, reaching USD XX billion by 2031.
Key Market Insights
Atopic dermatitis, a chronic inflammatory skin disorder, necessitates long-term management through topical therapies, systemic treatments, and lifestyle modifications. The emergence of biologic drugs, advanced topical formulations, and personalized dermatology solutions is transforming treatment approaches.
Growth Drivers
- Increasing Prevalence of Atopic Dermatitis – The rising incidence of eczema and allergic skin disorders is driving market growth.
- Advancements in Biologic Therapies & Non-Steroidal Treatments – The development of monoclonal antibodies, JAK inhibitors, and targeted immune modulators is enhancing patient outcomes.
- Rising Awareness & Dermatology Treatment Accessibility – Growing skincare awareness and efforts toward early diagnosis are increasing treatment adoption.
- Expansion of Prescription & Over-the-Counter (OTC) Dermatology Products – The availability of moisturizers, barrier creams, and anti-inflammatory skincare solutions is increasing.
Regional Trends
- North America leads because of strong research in dermatological treatments and high adoption of biologics.
- Europe is growing with regulatory approvals for new atopic dermatitis medications.
- The Asia-Pacific region is experiencing rapid growth, driven by increasing prevalence of skin disorders and rising consumer awareness.
- Latin America and the Middle East & Africa are emerging markets that benefit from expanding dermatology-focused healthcare programs.
ClearView Market Insights Analysis;
The Atopic Dermatitis Treatment Market is poised for ongoing expansion, fueled by advancements in biologic therapies, heightened awareness of skin health, and improved access to dermatology treatments. Companies focusing on personalized dermatology, cutting-edge topical therapies, and immune-modulating drugs will lead this evolving sector.
Reasons To Buy
nan
Scope
nan
Key Players
- Sanofi S.A.
- Regeneron Pharmaceuticals
- Inc.
- Pfizer Inc.
- LEO Pharma A/S
- AbbVie Inc.
Atopic Dermatitis Treatment Market Report
- 1. Atopic Dermatitis Treatment Market Research Report
- 1.1 Study Objectives
- 1.2 Atopic Dermatitis Treatment Market - Overview
- 1.3 Reason to Read This Report
- 1.4 Methodology and Forecast Analysis
- 2.1 Atopic Dermatitis Treatment Market Research Report – Detailed Scope and Definitions
- 2.1.1 By Type
- 2.1.2 By Route of Administration
- 2.1.3 By Distribution Channel
- 2.1.4 By Region
- 2.1.5 By Region
- 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
- 3.2. Restraints – By Type, By Route of Administration, By Distribution Channel, By Region, By Country
- 3.3. Opportunities – By Type, By Route of Administration, By Distribution Channel, By Region, By Country
- 3.4. Trends – By Type, By Route of Administration, By Distribution Channel, By Region, By Country
- 3.5. PEST Analysis
- 3.6. Porters Five Rule Analysis
- 3.7. Company’s Share Analysis (CSA) by Region or By Country
- 3.8. Atopic Dermatitis Treatment Market Research Report – DROTs Impact Analysis
- 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
- 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
- 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.1 Topical Corticosteroids
- 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.2 Calcineurin Inhibitors
- 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.3 PDE4 Inhibitors
- 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.4 Biologics
- 5.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.1 Topical
- 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.2 Oral
- 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.3 Injectable
- 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.1 Hospital Pharmacies
- 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.2 Retail Pharmacies
- 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.3 Online Pharmacies
- 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.1 North America
- 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.2 Europe
- 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.3 Asia-Pacific
- 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.4 Latin America
- 8.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.5 Middle East & Africa
- 8.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 9.1 North America
- 9.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 9.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 9.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 9.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 9.2 Europe
- 9.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 9.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 9.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 9.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 9.3 Asia-Pacific
- 9.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 9.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 9.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 9.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 9.4 Latin America
- 9.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 9.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 9.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 9.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 9.5 Middle East & Africa
- 9.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 9.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 9.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 9.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 9.6 Atopic Dermatitis Treatment Market - Opportunity Analysis Index, By Type, By Route of Administration, By Distribution Channel, By Region, and Region, 2024 - 2031
- 10.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 10.1.1 Topical Corticosteroids
- 10.1.2 Calcineurin Inhibitors
- 10.1.3 PDE4 Inhibitors
- 10.1.4 Biologics
- 10.2.1 Topical
- 10.2.2 Oral
- 10.2.3 Injectable
- 10.3.1 Hospital Pharmacies
- 10.3.2 Retail Pharmacies
- 10.3.3 Online Pharmacies
- 10.4.1 North America
- 10.4.2 Europe
- 10.4.3 Asia-Pacific
- 10.4.4 Latin America
- 10.4.5 Middle East & Africa
- 10.5.1 United States
- 10.5.2 Canada
10.7 Regional Trends Analysis
10.8 North America Atopic Dermatitis Treatment Market Research Report - Company Profiles- 10.8.1 Company 1 (United States)
- 10.8.2 Company 2 (Canada)
- 10.8.3 Company 3 (Canada)
- 11.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 11.1.1 Topical Corticosteroids
- 11.1.2 Calcineurin Inhibitors
- 11.1.3 PDE4 Inhibitors
- 11.1.4 Biologics
- 11.2.1 Topical
- 11.2.2 Oral
- 11.2.3 Injectable
- 11.3.1 Hospital Pharmacies
- 11.3.2 Retail Pharmacies
- 11.3.3 Online Pharmacies
- 11.4.1 North America
- 11.4.2 Europe
- 11.4.3 Asia-Pacific
- 11.4.4 Latin America
- 11.4.5 Middle East & Africa
- 11.5.1 Germany
- 11.5.2 United Kingdom
- 11.5.3 France
- 11.5.4 Spain
- 11.5.5 Italy
- 11.5.6 Russia
- 11.5.7 Netherlands
- 11.5.8 Poland
- 11.5.9 Rest of Europe
11.7 Regional Trends Analysis
11.8 Europe Atopic Dermatitis Treatment Market Research Report - Company Profiles- 11.8.1 Company 1 (Germany)
- 11.8.2 Company 2 (United Kingdom)
- 11.8.3 Company 3 (United Kingdom)
- 12.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 12.1.1 Topical Corticosteroids
- 12.1.2 Calcineurin Inhibitors
- 12.1.3 PDE4 Inhibitors
- 12.1.4 Biologics
- 12.2.1 Topical
- 12.2.2 Oral
- 12.2.3 Injectable
- 12.3.1 Hospital Pharmacies
- 12.3.2 Retail Pharmacies
- 12.3.3 Online Pharmacies
- 12.4.1 North America
- 12.4.2 Europe
- 12.4.3 Asia-Pacific
- 12.4.4 Latin America
- 12.4.5 Middle East & Africa
- 12.5.1 China
- 12.5.2 Japan
- 12.5.3 India
- 12.5.4 South Korea
- 12.5.5 Australia & NZ
- 12.5.6 ASEAN
- 12.5.7 Rest of Asia-Pacific
12.7 Regional Trends Analysis
12.8 Asia-Pacific Atopic Dermatitis Treatment Market Research Report - Company Profiles- 12.8.1 Company 1 (China)
- 12.8.2 Company 2 (Japan)
- 12.8.3 Company 3 (Japan)
- 13.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 13.1.1 Topical Corticosteroids
- 13.1.2 Calcineurin Inhibitors
- 13.1.3 PDE4 Inhibitors
- 13.1.4 Biologics
- 13.2.1 Topical
- 13.2.2 Oral
- 13.2.3 Injectable
- 13.3.1 Hospital Pharmacies
- 13.3.2 Retail Pharmacies
- 13.3.3 Online Pharmacies
- 13.4.1 North America
- 13.4.2 Europe
- 13.4.3 Asia-Pacific
- 13.4.4 Latin America
- 13.4.5 Middle East & Africa
- 13.5.1 Brazil
- 13.5.2 Mexico
- 13.5.3 Argentina
- 13.5.4 Peru
- 13.5.5 Colombia
- 13.5.6 Rest of Latin America
13.7 Regional Trends Analysis
13.8 Latin America Atopic Dermatitis Treatment Market Research Report - Company Profiles- 13.8.1 Company 1 (Brazil)
- 13.8.2 Company 2 (Mexico)
- 13.8.3 Company 3 (Mexico)
- 14.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 14.1.1 Topical Corticosteroids
- 14.1.2 Calcineurin Inhibitors
- 14.1.3 PDE4 Inhibitors
- 14.1.4 Biologics
- 14.2.1 Topical
- 14.2.2 Oral
- 14.2.3 Injectable
- 14.3.1 Hospital Pharmacies
- 14.3.2 Retail Pharmacies
- 14.3.3 Online Pharmacies
- 14.4.1 North America
- 14.4.2 Europe
- 14.4.3 Asia-Pacific
- 14.4.4 Latin America
- 14.4.5 Middle East & Africa
- 14.5.1 Saudi Arabia
- 14.5.2 UAE
- 14.5.3 South Africa
- 14.5.4 Egypt
- 14.5.5 Israel
- 14.5.6 Rest of Middle East and Africa
14.7 Regional Trends Analysis
14.8 Middle East & Africa Atopic Dermatitis Treatment Market Research Report - Company Profiles- 14.8.1 Company 1 (Saudi Arabia)
- 14.8.2 Company 2 (UAE)
- 14.8.3 Company 3 (UAE)
- 15.1 Strategic Dashboard of Top Market Players
15.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)- 15.2.1 Sanofi S.A.
- 15.2.2 Regeneron Pharmaceuticals
- 15.2.3 Inc.
- 15.2.4 Pfizer Inc.
- 15.2.5 LEO Pharma A/S
- 15.2.6 AbbVie Inc.
17. Principal Presumptions and Acronyms